Provided by Tiger Trade Technology Pte. Ltd.

Shuttle Pharmaceuticals Inc

0.5250
-0.0130-2.42%
Post-market: 0.53000.0050+0.95%19:52 EDT
Volume:288.10K
Turnover:152.32K
Market Cap:3.07M
PE:-0.09
High:0.5600
Open:0.5400
Low:0.5038
Close:0.5380
52wk High:6.19
52wk Low:0.5003
Shares:5.85M
Float Shares:5.82M
Volume Ratio:0.81
T/O Rate:4.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.7143
EPS(LYR):-7.1600
ROE:-326.36%
ROA:-81.65%
PB:0.92
PE(LYR):-0.07

Loading ...

Shuttle Pharmaceuticals shareholders approve reverse stock split authorization at annual meeting

Reuters
·
May 27

Shuttle Pharmaceuticals Q1 EPS $(0.43) Up From $(7.60) YoY

Benzinga
·
May 16

Shuttle Pharma Q1 FY26 net loss narrows 29% to $2.15 million

Reuters
·
May 16

Shuttle Pharmaceuticals closes United Dogecoin acquisition, creating public Dogecoin miner platform

Reuters
·
May 08

E.f. Hutton & Co. Serves as Exclusive M&a Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner

THOMSON REUTERS
·
May 08

Shuttle Pharmaceuticals agrees to merge with Dogecoin miner United Dogecoin

Reuters
·
May 01

Shuttle Pharmaceuticals announces annual shareholder meeting via webcast

Reuters
·
Apr 11

Shuttle Pharma FY25 net loss widens 28% to $11.7 million; operating loss deepens to $11.9 million

Reuters
·
Apr 01

BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services

Reuters
·
Mar 27

Shuttle Pharmaceuticals closes USD 3.5 million public offering

Reuters
·
Mar 12

Shuttle Pharmaceuticals announces USD 3.5 million public offering

Reuters
·
Mar 11

Shuttle Pharma FY2025 general and administrative expenses surge to USD 5.2–5.8 million from USD 1.4 million

Reuters
·
Feb 18

Shuttle Pharmaceuticals Extends Consulting Agreement With Interim Co-CEO at $20,000 Per Month

Reuters
·
Feb 03

Shuttle Pharmaceuticals Names Yuying Liang as Finance Chief

Dow Jones
·
Jan 13

BRIEF-Shuttle Pharmaceuticals Holdings Inc - Appoints Yuying Liang As CFO - SEC Filing

Reuters
·
Jan 13

Shuttle Pharmaceuticals Holdings Inc. Files Initial Beneficial Ownership Statement for CFO Yuying Liang

Reuters
·
Jan 13

Shuttle Pharmaceuticals Issues 320,496 Unregistered Shares in Asset Purchase Deal

Reuters
·
Dec 30, 2025

BRIEF-Shuttle Pharmaceuticals Holdings Inc - Timothy Lorber Resigns As CFO Of Shuttle Pharmaceuticals - SEC Filing

Reuters
·
Nov 29, 2025

Shuttle Pharmaceuticals Holdings Inc - Timothy Lorber Resigns as CFO of Shuttle Pharmaceuticals - SEC Filing

THOMSON REUTERS
·
Nov 29, 2025

Shuttle Pharmaceuticals Holdings Inc - Cooper Will Serve in This Capacity While Com Conducts Search for Permanent CFO

THOMSON REUTERS
·
Nov 29, 2025